Delve vs Atomic
Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC W24 AI compliance automation for SOC 2/HIPAA/ISO/GDPR at $35.8M total ($32M Insight Partners Series A 2025 at $300M val); 500+ companies, profitable, doubling quarterly competing with Vanta and Drata for AI-native evidence collection.
About
Delve is a San Francisco-based AI-native compliance automation platform — backed by Y Combinator (W24) with $35.8 million in total funding including a $3.3 million seed in 2024 from General Catalyst, FundersClub, Soma Capital, and YC, followed by a $32 million Series A in 2025 led by Insight Partners at a $300 million valuation — providing 500+ high-growth companies and Fortune 500 enterprises with AI agents that automatically collect security compliance evidence, map controls to frameworks, and maintain continuous compliance for SOC 2, HIPAA, ISO 27001, GDPR, PCI DSS, and custom regulatory frameworks. Profitable and doubling revenue quarterly, Delve's AI agents continuously gather compliance evidence from connected systems without the API-only approach that limits traditional compliance tools.
Venture studio co-founding 50+ companies including Hims & Hers; Jack Abraham's startup foundry providing capital, infrastructure, and operational support for new company creation.
About
Atomic (Atomic.vc) is a venture studio and startup foundry that co-founds companies alongside entrepreneurs, providing capital, infrastructure, talent networks, and operational support from ideation through early growth. Founded in 2012 by Jack Abraham (former VP Product at eBay after the acquisition of his startup Milo) and headquartered in San Francisco, Atomic has co-founded over 50 companies including Hims & Hers (NYSE: HIMS), OpenStore, Homebound, Fair, and numerous others, with a portfolio value that has reached into the billions.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.